28.02.2018 • NewsElaine BurridgeNippon SodaSyngenta

Syngenta and Nippon Soda Agree Seeds Deal

Syngenta, part of the ChemChina group since June 2017, has entered into a...
Syngenta, part of the ChemChina group since June 2017, has entered into a global licensing agreement with Nippon Soda for Picarbutrazox, a fungicide with a novel mode of action that has been developed by the Japanese company

Swiss seeds specialist Syngenta, part of the ChemChina group since June 2017, has entered into a global licensing agreement with Nippon Soda for Picarbutrazox, a fungicide with a novel mode of action that has been developed by the Japanese company.

Chinami Yokota, director of Nippon Soda’s development department, said the deal with Syngenta will broaden the use of Picarbutrazox beyond foliar application.

According to the companies, Picarbutrazox shows “robust and reliable performance” for controlling Pythium and seedling blight diseases under many different cropping systems.  Pythium, also known as root rot, damping off or water mold, is a fungus-like organism that affects hydroponic crops.

Tackling Pythium, they said, allows farmers to adopt reduced or no-tillage cropping systems protecting the soil, avoid the costs of replanting and benefit from better germination, strong stand establishment and higher yields.

“Picarbutrazox will strengthen Syngenta’s leading Pythium-control portfolio Mefenoxam and Azoxystrobin technology in corn, soybeans, canola, oilseed rape, cereals and other crops,” said Ioana Tudor, global head of Syngenta Seedcare.

The first commercial launch of Picarbutrazox for seed treatment is expected in the US and Canada in 2019.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.